Chongqing Pharscin Pharmaceutical (002907.SZ) has completed the domestic production drug registration for three products.
Huarson Pharmaceuticals (002907.SZ) announcement, the company recently obtained information from the website of the China Food and Drug Administration that the company's...
Chongqing Pharscin Pharmaceutical (002907.SZ) announced that the company recently obtained information from the website of the National Medical Products Administration that three of the company's products have completed the domestic production drug filing (application for drug instructions suitability for the elderly) and the filing information has been publicly posted on the website of the National Medical Products Administration. The related products are: Ba Wei Qi Long Granules, Teng Xie Ning Granules, and Gan Ju Bing Mei Pian.
Related Articles
HK Stock Market Move | Siasun Robot & Automation concept continues to rise, recent frequent industry chain exchanges, market preheating Tesla Optimus packaging.
Huachuang Securities: Maintain a "strong buy" rating on CONANT OPTICAL (02276) with a target price of HK$63.63.
HK Stock Market Move | Concept of SaaS Surges, Heavy Acquisition Serves as Agent's Repricing, Institutions Focus on Traditional SaaS Shift to Agent-oriented Paradigm Transition
HK Stock Market Move | Siasun Robot & Automation concept continues to rise, recent frequent industry chain exchanges, market preheating Tesla Optimus packaging.
Huachuang Securities: Maintain a "strong buy" rating on CONANT OPTICAL (02276) with a target price of HK$63.63.
HK Stock Market Move | Concept of SaaS Surges, Heavy Acquisition Serves as Agent's Repricing, Institutions Focus on Traditional SaaS Shift to Agent-oriented Paradigm Transition
